AzTrials
AzTrials

Research institution

Emory University Clinical Trials

Studies where Emory University is the lead sponsor: what is enrolling now, by phase, condition and country.

1,405 registered studies

In numbers

Open to volunteers
232
Active
274
With results posted
457
All registered
1,405

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 232
  • Sepsis

    Comparison of Sepsis Prediction Algorithms

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    Sepsis is a severe response to infection resulting in organ dysfunction and often leading to death. More than 1.5 million people get sepsis every year in the U.S., and 270,000 Americans die from sepsis annually.

    Trial name
    NCT05943938
    Testing
    Epic Sepsis Model Version - 1, Epic Sepsis Model Version - 2, Emory Sepsis Model
    Where
    7 sites in United States
    Volunteers
    1,200 people
    Sponsor
    Emory University
    Can I take part? NCT05943938
  • Multiple Sclerosis

    Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

    • Recruiting
    • Age: 18 to 89 years
    • Medical device

    The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than…

    Trial name
    DIIVA-MS (NCT06495138)
    Testing
    StableEyes
    Where
    United States
    Volunteers
    138 people, healthy volunteers welcome
    Sponsor
    Emory University
    Can I take part? DIIVA-MS
  • Sickle Cell Disease

    Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

    • Recruiting
    • Age: 7 to 18 years
    • Medical device

    The goal of this study is to evaluate the effects of transauricular vagus and trigeminal nerve stimulation on the treatment of pain in children with Sickle Cell Disease.

    Trial name
    NCT07090668
    Testing
    tAN device
    Where
    United States
    Volunteers
    20 people
    Sponsor
    Emory University
    Can I take part? NCT07090668
  • Malignant Female Reproductive System Neoplasm

    An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

    • Recruiting
    • Age: 18 years and older

    This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such…

    Trial name
    NCT06709534
    Testing
    Exercise Intervention, Functional Assessment, Medical Device Usage and Evaluation
    Where
    4 sites in United States
    Volunteers
    40 people
    Sponsor
    Emory University
    Can I take part? NCT06709534
  • End Stage Kidney Disease (ESKD), Hyperglycaemia

    Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who…

    Conditions
    End Stage Kidney Disease (ESKD), Hyperglycaemia, Diabetes
    Trial name
    NCT07880795
    Testing
    Continuous Glucose Monitoring (CGM)
    Where
    United States
    Volunteers
    180 people
    Sponsor
    Emory University
    Can I take part? NCT07880795
  • Osteosarcoma Recurrent, Osteosarcoma in Children

    Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

    • Recruiting
    • Age: 1 year to 30 years
    • Phase 1

    The goal of this clinical trial is to define the maximum tolerated dose (MTD) and/or Recommended phase 2 dose (RP2D) of Tegavivint in combination with Gemcitabine in patients with relapsed or refractory osteosarcoma (OS).

    Conditions
    Osteosarcoma Recurrent, Osteosarcoma in Children, Relapsed Osteosarcoma, Refractory Osteosarcoma
    Trial name
    NCT07144254
    Testing
    Tegavivint, Gemcitabine
    Where
    2 sites in United States
    Volunteers
    24 people
    Sponsor
    Emory University
    Can I take part? NCT07144254
  • Glioma

    Tumor Treating Fields for the Treatment of Brainstem Gliomas

    • Recruiting
    • Age: 18 years and older
    • Medical device

    This clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem.

    Trial name
    NCT05310448
    Testing
    Optune device
    Where
    3 sites in United States
    Volunteers
    10 people
    Sponsor
    Emory University
    Can I take part? NCT05310448
  • Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm

    Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

    • Recruiting
    • Age: 18 years and older
    • Early Phase 1
    • Surgery or procedure

    This early phase I trial evaluates different administration techniques (oral or intravenous) for arginine and tests the safety of giving arginine with whole brain radiation therapy in patients who have cancer that has spread from…

    Trial name
    NCT06328686
    Testing
    Arginine, Biospecimen Collection, Computed Tomography
    Where
    United States
    Volunteers
    10 people
    Sponsor
    Emory University
    Can I take part? NCT06328686
  • Prostate Carcinoma, Stage I Prostate Cancer AJCC v8

    CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer

    • Not yet recruiting
    • Age: 18 years and older
    • Surgery or procedure

    This clinical trial studies the safety of a computed tomography (CT) scan, with or without a magnetic resonance imaging (MRI) scan, in planning for high-dose-rate (HDR) prostate brachytherapy treatment in patients with prostate…

    Conditions
    Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8
    Trial name
    NCT07859722
    Testing
    Magnetic Resonance Imaging, Questionnaire Administration
    Where
    3 sites in United States
    Volunteers
    100 people
    Sponsor
    Emory University
  • Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8

    US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 2
    • Surgery or procedure

    This clinical trial studies how well ultrasound/photoacoustic/elasticity (US/PA/E) imaging works for early identification of tumor response in patients with stage II-III triple-negative breast cancer receiving immunotherapy and…

    Conditions
    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Triple-Negative Breast Carcinoma
    Trial name
    NCT07862751
    Testing
    Elastography, Magnetic Resonance Imaging, Photoacoustic Imaging
    Where
    United States
    Volunteers
    32 people
    Sponsor
    Emory University

Completed, with results posted

All 357
  • Polybrominated Biphenyl Poisoning

    Weight Loss Aid in an Exposed Population

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Results posted

    This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).

    Trial name
    NCT03582722
    Testing
    Orlistat, Multivitamin
    Where
    United States
    Volunteers
    100 people
    Sponsor
    Emory University
    Can I take part? NCT03582722
  • HIV

    Mental Health and Medication Adherence Among MSM in South Africa

    • Completed
    • Age: 18 years and older
    • Lifestyle or therapy programme
    • Results posted

    The goal of this behavioral study is to improve psychological well-being and optimization of HIV prevention and care outcomes for Men who have sex with men (MSM) in South Africa.

    Trial name
    NCT06880172
    Testing
    WeCare
    Where
    South Africa
    Volunteers
    12 people, healthy volunteers welcome
    Sponsor
    Emory University
  • Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV

    Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

    • Completed
    • Age: 18 years and older
    • Phase 2
    • Results posted

    This phase II trial studies whether rituximab and hyaluronidase human (Rituxan Hycela) can prevent immune related adverse events in participants with stage III-IV melanoma that cannot be removed by surgery who are undergoing…

    Conditions
    Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Stage III Melanoma, Stage IIIA Skin Melanoma
    Trial name
    NCT03719131
    Testing
    Nivolumab, Rituximab and Hyaluronidase Human, Ipilimumab
    Where
    United States
    Volunteers
    15 people
    Sponsor
    Emory University
  • Infant, Low Birth Weight

    Household Air Pollution and Health: A Multi-country LPG Intervention Trial

    • Completed
    • Age: 18 to 79 years
    • Results posted

    This study is a randomized controlled trial of liquefied petroleum gas (LPG) stove and fuel distribution in 3,200 households in four countries (India, Guatemala, Peru, and Rwanda).

    Trial name
    HAPIN (NCT02944682)
    Testing
    Liquefied petroleum gas (LPG) cookstove
    Where
    4 sites in Guatemala, India and 2 more
    Volunteers
    6,704 people
    Sponsor
    Emory University
    Can I take part? HAPIN
  • Chronic Pain, Post Traumatic Stress Disorder (PTSD)

    Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain

    • Completed
    • Age: 18 to 89 years
    • Medical device
    • Results posted

    The Veteran population has been known to deal with co-morbid chronic pain and PTSD. As a result, they use healthcare services at a higher rate than those Veterans with pain or PTSD alone which leads to an amplified burden on…

    Conditions
    Chronic Pain, Post Traumatic Stress Disorder (PTSD), Depression
    Trial name
    Warriors (NCT05254379)
    Testing
    tDCS
    Where
    United States
    Volunteers
    38 people
    Sponsor
    Emory University
    Can I take part? Warriors

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in